GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmocann Global Ltd (XTAE:PMCN-M) » Definitions » Net Margin %

Pharmocann Global (XTAE:PMCN-M) Net Margin % : 0.00% (As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Pharmocann Global Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Pharmocann Global's Net Income for the three months ended in Dec. 2023 was ₪0.00 Mil. Pharmocann Global's Revenue for the three months ended in Dec. 2023 was ₪0.00 Mil. Therefore, Pharmocann Global's net margin for the quarter that ended in Dec. 2023 was 0.00%.

The historical rank and industry rank for Pharmocann Global's Net Margin % or its related term are showing as below:

XTAE:PMCN-M' s Net Margin % Range Over the Past 10 Years
Min: -222.5   Med: -61.36   Max: 43.29
Current: -210.24


XTAE:PMCN-M's Net Margin % is ranked worse than
88.93% of 1021 companies
in the Drug Manufacturers industry
Industry Median: 3.25 vs XTAE:PMCN-M: -210.24

Pharmocann Global Net Margin % Historical Data

The historical data trend for Pharmocann Global's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmocann Global Net Margin % Chart

Pharmocann Global Annual Data
Trend Dec09 Dec10 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -222.50 12.96 -66.80 -111.47 -67.54

Pharmocann Global Quarterly Data
Dec17 Jun18 Dec18 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23 Dec23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -88.68 -160.86 -270.27 - -

Competitive Comparison of Pharmocann Global's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Pharmocann Global's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmocann Global's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharmocann Global's Net Margin % distribution charts can be found below:

* The bar in red indicates where Pharmocann Global's Net Margin % falls into.



Pharmocann Global Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Pharmocann Global's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-9.734/14.413
=-67.54 %

Pharmocann Global's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=0/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharmocann Global  (XTAE:PMCN-M) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Pharmocann Global Net Margin % Related Terms

Thank you for viewing the detailed overview of Pharmocann Global's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmocann Global (XTAE:PMCN-M) Business Description

Traded in Other Exchanges
N/A
Address
Ramat Yishai, PO Box 305, Kiryat Tivon, ISR, 3601201
Pharmocann Global Ltd is an Israel-based company engaged in producing medical-related cannabis products which include oil, ointments, tablets, inhalers, rectal and vaginal suppositories, and pre-rolled cigarettes of various types of THC/CBD strains.

Pharmocann Global (XTAE:PMCN-M) Headlines

No Headlines